McGuire DVAMC GI (111N)
Richmond, Virginia, United States
Doctor in Richmond, Virginia
1201 Broad Rock Blvd, Richmond, VA 23249
About McGuire DVAMC GI (111N)
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Biogen
1
Galapagos NV
1
Inflabloc Pharmaceuticals
1
Clinical Trials at McGuire DVAMC GI (111N)
During the past decade, McGuire DVAMC GI (111N) conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Clinical Trial of Natalizumab in Individuals With Moderately to Severely Active Crohn's Disease
2004-03-01
2005-03-01
Completed
462
An Efficacy and Safety Evaluation of Inflabloc Cap in the Treatment of Patients With Crohn's Disease
2005-01-01
2006-10-01
Completed
75
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease
2016-10-31
2022-11-11
Completed
1,374
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "McGuire DVAMC GI (111N)"
#1 collaborator was "Elan Pharmaceuticals" with 1 trials as a collaborator and "Gilead Sciences" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at McGuire DVAMC GI (111N)
According to Clinical.Site data, the most researched conditions in "McGuire DVAMC GI (111N)" are
"Crohn's Disease" (3 trials). Many other conditions were trialed in "McGuire DVAMC GI (111N)" in a lesser frequency.
Clinical Trials Intervention Types at McGuire DVAMC GI (111N)
Most popular intervention types in "McGuire DVAMC GI (111N)" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Dehydroepiandrosterone [DHEA]" (1 trials), "Filgotinib" (1 trials), "Placebo to match filgotinib" (1 trials) and "natalizumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at McGuire DVAMC GI (111N)
The vast majority of trials in "McGuire DVAMC GI (111N)" are
3 trials for "All" genders.
Clinical Trials Status at McGuire DVAMC GI (111N)
Currently, there are NaN active trials in "McGuire DVAMC GI (111N)".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in McGuire DVAMC GI (111N),
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in McGuire DVAMC GI (111N), 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".